[
  {
    "ts": "2025-02-01T12:07:00+00:00",
    "headline": "Jim Cramer on IDEXX Laboratories, Inc. (IDXX): ‘I Think The Company Should Benefit From A Continued Comeback For Vet Visits’",
    "summary": "We recently compiled a list of the Jim Cramer Looked At These 7 Stocks Recently. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the other stocks Jim Cramer recently looked at. On Mad Money, Jim Cramer recently delved into the impact of previous President Joe Biden’s […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-idexx-laboratories-inc-120700896.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "66fe14d5-7bf0-3411-ac32-d7f2e2145254",
      "content": {
        "id": "66fe14d5-7bf0-3411-ac32-d7f2e2145254",
        "contentType": "STORY",
        "title": "Jim Cramer on IDEXX Laboratories, Inc. (IDXX): ‘I Think The Company Should Benefit From A Continued Comeback For Vet Visits’",
        "description": "",
        "summary": "We recently compiled a list of the Jim Cramer Looked At These 7 Stocks Recently. In this article, we are going to take a look at where IDEXX Laboratories, Inc. (NASDAQ:IDXX) stands against the other stocks Jim Cramer recently looked at. On Mad Money, Jim Cramer recently delved into the impact of previous President Joe Biden’s […]",
        "pubDate": "2025-02-01T12:07:00Z",
        "displayTime": "2025-02-01T12:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sd7C_hJ_TJUCWDWXLnDlaA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QFqTatZh3Do84XbW2kldpA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3c224eddc6da8c7c88aca873db35fba6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-idexx-laboratories-inc-120700896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-idexx-laboratories-inc-120700896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IDXX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]